Results 101 to 110 of about 17,831 (181)

Image_1_Kikuchi-Fujimoto disease evolves into lupus encephalopathy characterized by venous sinus thrombosis: a case report.tif

Kikuchi-Fujimoto disease (KFD) is a benign, self-limiting illness that can progress to systemic lupus erythematosus (SLE) in approximately 30% of cases. Neurological injuries can occur in both diseases, albeit with distinct presentations.
Jiayu Tian (2363389), Wenyi Qin (4870177), Mengqi Liu (302126), Shuangshuang Yang (1884151), Juan Yang (384075), Xiaofeng Rong (13985325), Guoqing Zhou (794344), Lijuan Zhang (36878)   +7 more
core   +1 more source

Nine fatal cases of dengue: a case series from an intensive care unit in Sri Lanka

Tropical Medicine and Health
Background The case fatality rate of untreated dengue is 20%; it can be reduced to less than 1% with optimal management. The leading causes of death in dengue patients are shock, bleeding, and acute liver injury.
Pramith Ruwanpathirana, Harindri Athukorala, Thamalee Palliyaguru, Praveen Weeratunga, Dilshan Priyankara   +4 more
doaj   +1 more source

Distribution and parameter limits for the transition probabilities in the model as used in the probabilistic sensitivity analysis.

, 2016
CI, confidence interval; r VTE, recurrent venous thromboembolism; MCRB, major or clinically relevant bleeding; VKA, vitamin K antagonists; HR, hazard ratio; D, Dirichlet distribution applying to 2 or 3 linked probabilities with the parameter ...
J. Stevanović (3238986), E. P. Dvortsin (3238992), B. S. Kappelhoff (3238989), M. Voorhaar (3238983), L. A. de Jong (3238980), M. J. Postma (3168759)   +5 more
core   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage

, 2015
Background Whether and when to resume oral anticoagulant therapy for patients who survive warfarin-related intracranial hemorrhage (ICH) remains a dilemma lacking consensus recommendations and high-quality evidence to guide clinical decision making ...
Crowther, Mark A., Witt, Daniel M., Martinez, Kerri, DENTALI, FRANCESCO, Hylek, Elaine, Delate, Thomas, Schroeder, Allison, AGENO, WALTER, Clark, Nathan P., Garcia, David, Ye, Xiangyang   +10 more
core   +1 more source

Intracranial hemorrhage in adults on ECMO

, 2018
Rationale: Extracorporeal membrane oxygenation (ECMO) use has exploded over the last decade. However, it remains invasive and associated with significant complications, including tamponade, infection, thrombosis, gas embolism and bleeding.
Yiorgos Alexandros Cavayas, Eddy Fan, Lorenzo del Sorbo   +2 more
core   +1 more source

Efficacy and safety of reduced-dose non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation: A meta-analysis of randomized controlled trials

, 2019
Aims Non-vitamin K antagonist oral anticoagulants (NOACs) require dose reductions according to patient or clinical fac tors for patients with atrial fibrillation (AF).
Patel, Manesh R., Büller, Harry R., Wang, Kang-Ling, Giugliano, Robert P., Tan, Doreen Su-Yin, Chiang, Chern-En, Lopes, Renato D.   +6 more
core   +1 more source

Endovascular Treatment in Patients with Large Vessel Occlusion Stroke of Different Mechanisms

Neurology and Therapy
Introduction Acute ischemic stroke with large vessel occlusion (AIS-LVO) is mainly caused by in situ thrombosis (IST), artery-to-artery embolism (AAE), and cardioembolism (CE). The clinical characteristics and prognosis of each mechanism are unclear in a
Zhiyuan Feng, Ming Yang, Aoming Jin, Ning Ma, Feng Gao, Dapeng Mo, Xiaojuan Liu, Fangyuan Zhang, Xinchen Li, Yimeng Li, Qi Chu, Jing Xue, Aichun Cheng, Jinxi Lin, Hao Li, Xia Meng, Zhongrong Miao, Yongjun Wang, Jie Xu   +18 more
doaj   +1 more source

Breaking the blockage by advancing treatment strategies for upper extremity deep vein thrombosis. [PDF]

J Vasc Surg Venous Lymphat Disord
Chidurala S, Patel M, Farrell E, Perry LD, Pounds LL, Sideman MJ, Andersen JC.   +6 more
europepmc   +1 more source